NEW YORK - A federal judge will allow a breach-of-contract claim by Johnson & Johnson to proceed in a $5.5 billion lawsuit over Boston Scientific Corporation's acquisition of heart-device maker Guidant last year.
In a ruling signed Wednesday and made public Thursday, U.S. District Judge Gerard Lynch in New York denied a motion by Boston Scientific and Guidant to dismiss a breach-of-contract claim related to Guidant's termination of a merger agreement with Johnson & Johnson last year.
However, the judge granted a motion to dismiss claims that Natick, Mass.-based Boston Scientific and Guidant violated an implied duty of good faith and fair dealing in the Guidant-Johnson & Johnson merger agreement, saying there is no basis under Indiana law for a claim of violation of such a duty. The contract is governed by Indiana law.
"We're pleased that the majority of the claims were dismissed," said Paul Donovan, a Boston Scientific spokesman. "We continue to believe the remaining claim is without merit."
DOW JONES NEWS SERVICE
As you read this blog entry, angel investors and start-ups are flocking to Madison, Wisconsin for the annual Wisconsin Early Stage Symposium and the Mid West Health Care Venture forum.
Comment on this story | Be the first to comment | Hide reader comments